Medical composition containing amorphous atorvastatin calcium
Patent Information
- Authority / Receiving Office
- CN · China
- Patent Type
- Applications(China)
- Current Assignee / Owner
- BEIJING D VENTUREPHARM TECH DEV
- Publication Date
- 2010-07-07
- Estimated Expiration
- Not applicable · inactive patent
Smart Images
Figure 1 Figure 2 Figure 3
Abstract
Description
technical field
[0001] The invention discloses a pharmaceutical composition for treating hypercholesterolemia, in particular to a pharmaceutical composition containing amorphous atorvastatin calcium. Background technique
[0002] The chemical name of atorvastatin is: [R-(R,R)]-2-(4-fluorophenyl)-β,β-dihydroxy-5-(1-methylethyl)-3-benzene Calcium-4-[(aniline)carbonyl]-1hydro-pyrrole-1-heptanoate trihydrate. This product is a selective and competitive 3-hydroxy-3-methylglutaryl coenzyme A (HMG-C) synthesized in recent years 0 A) Reductase inhibitor, the lipid-lowering effect is higher than other HMG-C 0 A reductase inhibitor. The clinical use of atorvastatin calcium has definite curative effect and remarkable effect, but because atorvastatin calcium has a bitter taste and is very slightly soluble in water, it is very sensitive to light, temperature and humidity. Therefore, there are problems such as poor stability, delayed disintegration, and slow dissolution in clinical pr...